Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Van der Meer

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Vox Sanguinis|June 9, 2005
Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurementsJ R Hess, L R Kagen, P F van der Meer, et al.
Blood Vessels, Thrombosis & Hemostasis|April 13, 2026
Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patientsDiana Muñoz Sandoval, Eva R Smit, Felipe Rojas-Rodriguez, et al.
Transfusion|September 4, 2025
Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato-oncological patientsEva R Smit, Isabella Viegen, Pieter F van der Meer, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2022
Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusionsThijs L J van Osch, Tamas Pongracz, Dionne M Geerdes, et al.
Ophthalmology and Therapy|October 16, 2023
Allogeneic Serum Eye Drops: A Randomized Clinical Trial to Evaluate the Clinical Effectiveness of Two Drop SizesChristie Vermeulen, Lars L J van der Burg, Nan van Geloven, et al.
Acta Psychiatrica Scandinavica|September 3, 2011
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosisS Dragt, D H Nieman, F Schultze-Lutter, et al.
Blood|May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trialPieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Vox Sanguinis|March 25, 2025
Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre studyChristie Vermeulen, Nan van Geloven, Bart Mertens, et al.
BMC Cancer|February 24, 2020
Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial)B F Kingma, W J Eshuis, E M de Groot, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS studyJ W T van der Wel, S M Ernst, M Jebbink, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Vox Sanguinis|June 9, 2005
Interlaboratory comparison of red-cell ATP, 2,3-diphosphoglycerate and haemolysis measurementsJ R Hess, L R Kagen, P F van der Meer, et al.
Blood Vessels, Thrombosis & Hemostasis|April 13, 2026
Hemostatic and platelet proteins are associated with bleeding grade and time to major bleed in hemato-oncological patientsDiana Muñoz Sandoval, Eva R Smit, Felipe Rojas-Rodriguez, et al.
Transfusion|September 4, 2025
Impact of platelet transfusions on plasma proteomes in controlled endotoxemia and in hemato-oncological patientsEva R Smit, Isabella Viegen, Pieter F van der Meer, et al.
Journal of Thrombosis and Haemostasis : JTH|September 27, 2022
Altered Fc glycosylation of anti-HLA alloantibodies in hemato-oncological patients receiving platelet transfusionsThijs L J van Osch, Tamas Pongracz, Dionne M Geerdes, et al.
Ophthalmology and Therapy|October 16, 2023
Allogeneic Serum Eye Drops: A Randomized Clinical Trial to Evaluate the Clinical Effectiveness of Two Drop SizesChristie Vermeulen, Lars L J van der Burg, Nan van Geloven, et al.
Acta Psychiatrica Scandinavica|September 3, 2011
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosisS Dragt, D H Nieman, F Schultze-Lutter, et al.
Blood|May 19, 2018
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trialPieter F van der Meer, Paula F Ypma, Nan van Geloven, et al.
Vox Sanguinis|March 25, 2025
Clinical evaluation of red cell concentrates in non-DEHP plasticized containers compared with standard DEHP plasticized containers: A quasi-randomized observational multicentre studyChristie Vermeulen, Nan van Geloven, Bart Mertens, et al.
BMC Cancer|February 24, 2020
Paravertebral catheter versus EPidural analgesia in Minimally invasive Esophageal resectioN: a randomized controlled multicenter trial (PEPMEN trial)B F Kingma, W J Eshuis, E M de Groot, et al.
Lung Cancer (Amsterdam, Netherlands)|October 3, 2025
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS studyJ W T van der Wel, S M Ernst, M Jebbink, et al.
Pageof 13